Drug Trial Radar · NCT02260492
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Last checked: Nov 19, 2026Latest source record: Jun 15, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
879
Actual
Start
Sep 2014
Primary completion
May 2015
Study completion Jul 2015
Sponsor
- Lead sponsor
- Oriel TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 9, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to establish the equivalence of OT329 Solis and Advair Diskus when administered by inhalation in patients with asthma.
Conditions
- Asthma
Interventions
OT329 (combination of fluticasone propionate and salmeterol xinafoate)Drug
Fluticasone propionate (100 mcg) and salmeterol xinafoate (50 mcg) administered by Solis dry powder inhaler
Advair Diskus (combination of fluticasone propionate and salmeterol xinafoate)Drug
Fluticasone propionate (100 mcg) and salmeterol xinafoate (50 mcg) administered by Diskus dry powder inhaler
PlaceboDrug
Placebo (lactose) administered via the Solis dry powder inhaler
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Serial FEV1-time Curve (AUC 0-12h)Time frame: 0-12 hours after dosing on Day 1
- FEV1 TroughTime frame: Post-4 weeks of treatment
Locations
47 sites in 1 country. Site status is shown where the registry gives one.
Oriel Investigative Site
Goodyear, Arizona
Oriel Investigative Site
Tempe, Arizona
Oriel Investigative Site
Anaheim, California
Oriel Investigative Site
Los Angeles, California
Oriel Invetigative Site
Los Angeles, California
Oriel Investigative Site
Mission Viejo, California
Oriel Investigative Site
Centennial, Colorado
Oriel Investigative Site
Clearwater, Florida
Oriel Investigative Site
Coral Gables, Florida
Oriel Investigative Site
Homestead, Florida
Oriel Investigative Site
Jupiter, Florida
Oriel Investigative Site
Kissimee, Florida
Oriel Investigative Site
Miami, Florida
Oriel Investigative Site
New Port Richie, Florida
Oriel Investigative Site
Orlando, Florida
Oriel Investigative Site
Tallahassee, Florida
Oriel Investigative Site
Lawrenceville, Georgia
Oriel Investigative Site
Iowa City, Iowa
Oriel Investigative Site
North Dartmouth, Massachusetts
Oriel Therapeutics Site
Minneapolis, Minnesota
Oriel Investigative Site
St Louis, Missouri
Oriel Investigative Site
Bellevue, Nebraska
Oriel Investigative Site
Omaha, Nebraska
Oriel Investigative Site
Skillman, New Jersey
Oriel Investigative Site
Albuquerque, New Mexico
Oriel Investigative Site
New York, New York
Oriel Investigative Site
Charlotte, North Carolina
Oriel Investigative Site
Raleigh, North Carolina
Oriel Investigative Site
Winston-Salem, North Carolina
Oriel Investigative Site
Cincinnati, Ohio
Oriel Investigative Site
Cincinnati, Ohio
Oriel Investigative Site
Middleburg Heights, Ohio
Oriel Investigative Site
Toledo, Ohio
Oriel Investigative Site
Oklahoma City, Oklahoma
Oriel Investigative Site
Eugene, Oregon
Oriel Investigative Site
Medford, Oregon
Oriel Investigative Site
Portland, Oregon
Oriel Investigative Site
Providence, Rhode Island
Oriel Investigative Site
Warwick, Rhode Island
Oriel Investigative Site
Rock Hill, South Carolina
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.